Akina Takami

7PUBLICATIONS
5CO-AUTHORS
Gene and molecular therapyPharmacogenomicsEconomic models and forecastingToxicology (incl. clinical toxicology)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2026
The Multiple Criteria Qualitative Value-Based Pricing Framework "MARIE" for Novel Cell and Gene Therapy.

|Mar 30, 2026
Author's reply to 'Trends in Usage and Drug Costs of Immune-Checkpoint Inhibitors in Japan'.

Akina Takami, Koki Yamashita, Ataru Igarashi

|Mar 27, 2026
Updated Conversion Table for the Multiple Criteria Qualitative Value-Based Pricing Framework "MARIE".

Akina Takami, Ataru Igarashi

|Mar 26, 2026
Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan.

Akina Takami, Gen Terashima, Yuichi Shiotsuki

|Jan 12, 2026
Trends in Adverse Event Reports of Dipeptidyl Peptidase-4 Inhibitor-Associated Pemphigoid in Japan.

Akina Takami, Gen Terashima, Takumi Tajima

|Dec 02, 2025
Trends in usage and drug costs of immune checkpoint inhibitors in Japan.

Akina Takami, Koki Yamashita, Ataru Igarashi

Pageof 2

Frequent Collaborators

5 joint publications

Ataru Igarashi

3 joint publications

Koki Yamashita

2 joint publications

Gen Terashima

1 joint publications

Takumi Tajima